D. E. Shaw & Co., Inc. Bio Techne Corp Call Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $6.94 Million - $8.41 Million	-15,600 Reduced 76.47%	4,800 $2.33 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $2.52 Million - $2.93 Million	6,500 Added 46.76%	20,400 $9.19 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $566,316 - $739,800	-1,800 Reduced 11.46%	13,900 $5.31 Million
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $2.25 Million - $2.93 Million	9,100 Added 137.88%	15,700 $4.99 Million
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $1.53 Million - $1.87 Million	6,600 New	6,600 $1.64 Million

610

152M

171K

56.9K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.93B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.